Green Cross Medical Science Corporation (142280) — Capital Reinvestment Ratio
Green Cross Medical Science Corporation (142280) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩5.01 Billion) in capital expenditures (₩460.89 Million). See Green Cross Medical Science Corporation net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Medical Science Corporation Capital Reinvestment Ratio (2016–2025)
This chart tracks Green Cross Medical Science Corporation's Capital Reinvestment Ratio across 6 annual periods. Check total reinvestment intensity of Green Cross Medical Science Corporation to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Green Cross Medical Science Corporation (2016–2025)
Year-by-year Capital Reinvestment Ratio for Green Cross Medical Science Corporation from 2016 to 2025. For live market cap and broader valuation context, see market value of Green Cross Medical Science Corporation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | ₩7.20 Billion | ₩4.90 Billion | ▼ -22.5% |
| 2024 | 0.88x | ₩3.66 Billion | ₩3.22 Billion | ▼ -33.9% |
| 2023 | 1.33x | ₩4.24 Billion | ₩5.63 Billion | ▲ +321.7% |
| 2022 | 0.31x | ₩10.88 Billion | ₩3.43 Billion | ▼ -11.4% |
| 2017 | 0.36x | ₩3.11 Billion | ₩1.11 Billion | ▲ +93.2% |
| 2016 | 0.18x | ₩10.25 Billion | ₩1.89 Billion | — |